Liposomes, liquid-crystal systems, lipid nanoparticles and nanoemulsions may solve different stability or delivery problems. Particle size alone cannot describe performance, exposure or safety.
Define the problem before selecting the carrier
A carrier may be intended to improve dispersion, protect an unstable material, change release, increase deposition or alter sensory behaviour. These objectives are different and need different controls.
Calling a system nano does not show which problem it solves. Composition, structure, loading, release and behaviour in the complete formula must be characterised.
Delivery, deposition and penetration are not synonyms
More material detected in a skin compartment can reflect surface deposition, follicular localisation, barrier interaction or deeper transport. The method and recovery procedure shape the interpretation.
A stronger study separates these locations and asks whether the observed exposure is necessary for the intended cosmetic function.
Safety and regulation start with design
Particle distribution, aggregation, material identity, impurities, long-term exposure and environmental fate should be considered alongside performance. Final-formula processing may also change the original carrier.
The minimum package includes structural characterisation, stability, loading and release, relevant skin-distribution controls, safety review and current target-market classification before claims are drafted.
Evidence and use boundary
English-edited from the approved GreenDee Muzi digest. Terminology, safety assessment and regulatory requirements must be checked for the exact material, product and market.